Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jul 31;9(8):2459. doi: 10.3390/jcm9082459

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Changes of central retinal thickness (CRT) from initial treatment according to the groups. In pachydrusen group, CRT significantly decreased from 408 ± 171 (baseline) to 190 ± 98, 185 ± 82, 190 ± 86, 202 ± 113 at 3 months, 6 months, 9 months, and 12 months, respectively. (all p-value < 0.001) In no drusen group, CRT significantly decreased from 373 ± 160 (baseline) to 202 ± 81, 210 ± 71, 215 ± 75, 218 ± 85 at 3 months, 6 months, 9 months, and 12 months, respectively. (all p-value < 0.001) In soft drusen group, CRT significantly decreased from 406 ± 210 (baseline) to 196 ± 69, 240 ± 113, 229 ± 114, 236 ± 122 at 3 months, 6 months, 9 months, and 12 months, respectively. (all p-value < 0.001) In PCV/Scarring group, CRT significantly decreased from 434 ± 132 (baseline) to 242 ± 99, 254 ± 114, 245.0 ± 84, 234 ± 83 at 3 months, 6 months, 9 months, and 12 months, respectively. (all p-value < 0.05).